Growth inhibitors in haemopoiesis and leukaemogenesis

Bailliere's Clinical Haematology

Volumn 10, Issue 3, 1997, Pages 539-559

  Graham, G J ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Cancer; Haemopoiesis; Inhibitors; Leukaemia; Stem cells

Indexed keywords

GROWTH INHIBITOR;

CELL PROLIFERATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; LEUKEMIA; LEUKEMOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0030691117     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(97)80025-X     Document Type: Article

References (135)

1. Alam R Forsythe P Stafford S Yoshiaki F Transforming growth factor β abrogates the effects of hematopoietins on eosinophils and induces their apoptosis Journal of Experimental Medicine 179 1994 1041 1045
2. Alkhatib G Combadiere C Broder CC CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV1 Science 272 1996 1955 1958
3. + progenitors Experimental Hematology 23 1995 551 556
4. Bonnet D Lemoine FM Frobert Y Thymosin β4, inhibitor for normal hematopoietic progenitor cells Experimental Hematology 24 1996 776 782
5. Brown PD Waterfield LM Levinson AD Sporn M Physicochemical activation of recombinant latent transforming growth factor-betas 1, 2 and 3 Growth Factors 3 1990 35 43
6. Broxmeyer HE Sherry B Lu L Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells Blood 76 1990 1110 1116
7. Broxmeyer HE Sherry B Cooper S Macrophage inflammatory protein (MIP)-1β abrogates the capacity of MIP-1α to suppress myeloid progenitor cell growth Journal of Immunology 147 1991 2586 2594
8. Burgess A Nicola N Growth Factors and Stem Cells 1983 Academic Press New York
9. Bursch W Oberhammer F Jirtle RL Transforming growth factor-β1 as a signal for induction of cell death by apoptosis British Journal of Cancer 67 1993 531 536
10. Bursuker I Neddermann KM Petty BA In vivo regulation of hemopoiesis by transforming growth factor beta 1: stimulation of GM-CSF and M-CSF dependent murine bone marrow precursors Experimental Hematology 20 1992 431 435
11. Carcamo J Weis FMB Ventura F Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin Molecular and Cellular Biology 14 1994 3810 3821
12. Carlino JA Higley HR Creson JR Transforming growth, factor β1 systematically modulates granuloid, lymphoid and thrombocytic cells in mice Experimental Hematology 20 1992 943 950
13. Cashman JD Eaves AC Eaves CJ The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: evidence for an indirect mechanism Blood 84 1994 1534 1542
14. Chang CM Limanni A Baker WH Bone marrow and splenic granulocyte-macrophage colony-stimulating factor and transforming growth factor-β mRNA levels in irradiated mice Blood 86 1995 2130 2136
15. Chasty RC Lucas GS Owen-Lynch PJ Macrophage inflammatory protein-1α receptors are present on cells enriched for CD34 expression from patients with chronic myeloid leukemia Blood 86 1995 4270 4277
16. Clements JM Craig S Gearing AJH Biological and structural properties of MIP-1α expressed in yeast Cytokine 4 1992 76 82
17. Cluitmans FHM Essendam BHJ Landegent JE Constitutive in vivo cytokine and haemopoietic growth factor gene expression in the bone marrow and peripheral blood of healthy individuals Blood 85 1995 2038 2044
18. + T cells Science 270 1995 1811 1815
19. Cook DN Beck MA Coffman TM Requirement of MIP-1α for inflammatory response to viral infection Science 269 1995 1583 1586
20. Cooper S Mantel C Broxmeyer HE Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1α Experimental Hematology 22 1994 186 193
21. Deng H Liu R Ellmeier W Identification of a major co-receptor for primary isolates of HIV-1 Nature 381 1996 661 666
22. Dickson MC Martin JS Cousins FM Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock-out mice Development 121 1995 1845 1854
23. Douglas MC Capocasale RJ Lamb RJ Chronic lymphocytic leukaemia B cells are resistant to the apoptotic effects of transforming growth factor-β Blood 89 1997 941 947
24. Dunlop DJ Wright EG Lorimore S Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP-1α in vivo Blood 79 1992 2221 2225
25. Eaves CJ Cashman JD Wolpe SD Eaves AC Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1α, an inhibitor of primitive normal hematopoietic cells Proceedings of the National Academy of Sciences of the USA 20 1993 12015 12019
26. Eaves CJ Cashman JD Kay RJ Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer Blood 78 1991 110 117
27. Eljo K Reichelt RL Hennings H Purified epidermal pentapeptide inhibits proliferation and enhances terminal differentiation in cultured mouse epidermal cells Journal of Investigative Dermatology 87 1986 555 558
28. Ferrajoli A Talpaz M Zipf TF Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1α Leukemia 8 1994 798 805
29. Frindel E Guigon M Inhibition of CFU entry into cycle by a bone marrow extract Experimental Hematology 5 1977 74 76
30. Frindel E Monpezat J-P The physiological role of the endogenous colony forming unit spleen (CFU-S) inhibitor acetyl-N-ser-asp-lys-pro (AcSDKP) Leukemia 3 1989 753 754
31. Frindel E Masse A Pradelles Ph Correlation of endogenous acetyl-ser-asp-lys-pro plasma levels in mice and the kinetics of the pluripotent hemopoietic stem cells entry into the cycle after cytosine arabinoside treatment: fundamental and clinical aspects Leukemia 6 1992 599 601
32. Frostad S Kalland T Aakvaag A Laerum OD Hemoregulatory peptide (HP5b) dimer effects on normal and malignant cells in culture Stem Cells 11 1993 303 311
33. Gewirtz AM Zhang J Ratajczak J Chemokine regulation of human megakaryocytopoiesis Blood 86 1995 2559 2567
34. Gilmore GL DePasquale DK Shadduck RK BB10010, a synthetic variant of MIP-1α, reduces neutropenic interval in cyclophosphamide treated mice Blood 88 1996 3270
35. Goey H Keller JR Black T Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-β1 Journal of Immunology 143 1989 877 882
36. Graham GJ Pragnell IB Treating cancer: the potential role of stem cell inhibitors European Journal of Cancer 27 1991 952 953
37. Graham GJ Pragnell IB The haemopoietic stem cell: properties and control mechanisms Seminars in Cell Biology 3 1992 423 434
38. Graham GJ Freshney MF Donaldson D Pragnell IB Purification and biochemical characterisation of human and murine stem cell inhibitors (SCI) Growth Factors 7 1992 151 160
39. Graham GJ Wright EG Hewick R Identification and characterisation of an inhibitor of haemopoietic stem cell proliferation Nature 344 1990 442 444
40. Graham GJ Mackenzie J Lowe S Aggregation of the chemokine MIP-1α is a dynamic and reversible phenomenon: biochemical and biological analyses Journal of Biological Chemistry 269 1994 4974 4978
41. Graham GJ Wilkinson PC Nibbs RJB Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1α by mutagenesis of the proteoglycan binding site EMBO Journal 15 1996 6506 6515
42. Grainger DJ Kemp PR Liu AC Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice Nature 370 1994 460 462
43. Grillon C Lenfant M Wdzieczak-Bakala J Optimization of cell culture conditions for the evaluation of the biological activities of the tetrapeptide N-acetyl-ser-asp-lys-pro, a natural hemoregulatory factor Growth Factors 9 1993 133 138
44. Grillon C Rieger K Wdzieczak-Bakala J Involvement of thymosin β4 and endoproteinase asp-N in the biosynthesis of the tetrapeptide ac-ser-asp-lys-pro, a regulator of the haematopoietic system FEBS Letters 274 1990 30 34
45. Grzegorzewski K Ruscetti FW Usui N Recombinant transforming growth factor beta (1) and beta (2) protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin Journal of Experimental Medicine 180 1994 1047 1057
46. Gupta SK Hassel T Singh JP A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4 Proceedings of the National Academy of Sciences of the USA 92 1995 7799 7803
47. Hakovirta H Vierula M Wolpe SD Parvinen M MIP-1 α is a regulator of mitotic and meiotic DNA-synthesis during spermatogenesis Molecular and Cellular Endocrinology 99 1994 119 124
48. Hannapepel E Leibold W Biosynthesis rates and content of thymosin-β4 in cell lines Archives of Biochemistry and Biophysics 240 1985 236 241
49. Hannapepel E Xu GJ Morgan J Thymosin-β4, a ubiquitous peptide in rat and mouse tissues Proceedings of the National Academy of Sciences of the USA 79 1982 217 221
50. Harrison DE Lerner CP Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil Blood 78 1991 1237 1240
51. Hatzfeld J Li M-L Brown EL Release of early human hematopoietic progenitors from quiescence by antisense transforming growth, factor β1 or Rb oligonucleotides Journal of Experimental Medicine 174 1991 925 929
52. Heufler C Topar G Koch F Cytokine gene expression in murine epidermal cell suspensions: interleukin-1 β and macrophage inflammatory protein 1 α are selectively expressed in Langerhans cells but are differentially regulated in culture Journal of Experimental Medicine 176 1992 1221 1226
53. Hong D-S Graham T Ewel C Inhibition of hematopoiesis in long-term marrow cultures established on adherent layers from AcSDKP-treated dogs Experimental Hematology 23 1995 639 644
54. (supplement) Holyoake TL Freshney MG Sproul AM Contrasting effects of rh-MIP-1α and TGF-β1 on chronic myeloid leukaemia progenitors in vitro Stem Cells 11 1993 S122 S128
55. Hunter MG Bawden L Brotherton D BB-10010: an active variant of human macrophage inflammatory protein-1β with improved pharmaceutical properties Blood 86 1995 4400 4408
56. Jacobsen FW Stokke T Jacobsen SEW Transforming growth factor-β potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells Blood 86 1995 2957 2966
57. Jacobsen SEW Keller JR Ruscetti FW Bidirectional effects of transforming growth factor β(TGF-β) on colony-stimulating factor-induced human myelopoiesis in vitro: differential effects of distinct TGF-β isoforms Blood 78 1991 2239 2247
58. Jacobsen SEW Ruscetti FW Dubois CM Transforming growth factor-β transmodulates the expression of colony-stimulating factor receptors on murine haemopoietic progenitor cell lines Blood 77 1991 1706 1716
59. Jones RJ Celano P Sharkis SJ Sensenbrenner LL Two phases of engraftment established by serial bone marrow transplantation in mice Blood 73 1989 397 401
60. Jones RJ Wagner JE Celano P Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells Nature 347 1990 188 189
61. Keller JR Barteimez SH Sitnicka E Distinct and overlapping direct effects of macrophage inflammatory protein-1α and transforming growth factor β on hematopoietic progenitor/stem cell growth Blood 84 1994 2175 2181
62. Khan S Wigley C Different effects of a macrophage cytokine on proliferation in astrocytes and Schwann cells Neuroreport 5 1994 1381 1385
63. King AG Talmadge JE Badger AM Pelus LM Regulation of colony-stimulating activity production from bone marrow stromal cells by the hemoregulatory peptide HP-5 Experimental Hematology 20 1992 223 228
64. Kulkarni AB Huh C Becker D Transforming growth factor-beta 1 null mutation in mice causes excessive inflammatory response and early death Proceedings of the National Academy of Sciences of the USA 90 1993 770 774
65. Laerum OD Maurer HR Proliferation kinetics of myelopoietic cells and macrophages in diffusion chambers after treatment with granulocyte extracts (chalones) Virchows Archives in Blood Cell Pathology 14 1973 293 305
66. Laerum OD Sletvold O Bjerknes R The dimer of hemoregulatory peptide (HP5B) stimulates mouse and human myelopoiesis in vitro Experimental Hematology 16 1988 274 280
67. Laterveer L Lindley IJD Heemskerk DPM Rapid mobilisation of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8 Blood 87 1996 781 788
68. Lathja LG Stem cell concepts Differentiation 14 1979 23 34
69. Lauret E Frindel E Miyanomae T Abrogation of the biological activity of the CFU-S inhibitor AcSDKP by a polyclonal antiserum Leukemia 3 1989 315 317
70. Lenfant M Wdzieczak-Bakala J Guittet E Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure Proceedings of the National Academy of Sciences of the USA 86 1989 779 782
71. Letterio JJ Geiser AG Kulkarni AB Maternal rescue of the transforming growth factorbeta knockout Science 264 1994 1936 1938
72. + hematopoietic progenitor cells Leukemia 8 1994 441 445
73. Lin HY Lodish HF Receptors for the TGF-β superfamily: multiple polypeptides and serine/threonine kinases Trends in Cell Biology 3 1993 14 19
74. Liu R Paxton WA Choe S Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection Cell 86 1996 367 377
75. Lord BI Dexter TM Clements JM Macrophage inflammatory protein protects multipotent haemopoietic cells from the cytotoxic effects of hydroxyurea in vivo Blood 79 1992 2605 2609
76. Lord BI Woolford LB Wood LM Mobilisation of early hematopoietic progenitor cells with BB-10010: a genetically engineered variant of human macrophage inflammatory protein-1 alpha Blood 85 1995 3412 3415
77. Lotem J Sachs L Hematopoietic cytokines inhibit apoptosis induced by transforming growth-factor β1 and cancer chemotherapy compounds in myeloid leukemic cells Blood 80 1992 1750 1757
78. Lotz M Ranheim E Kipps TJ Transforming growth factor-β as endogenous growth inhibitor of chronic lymphocytic leukaemia B cells Journal of Experimental Medicine 179 1994 999 1004
79. + human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokinemediated hematopoietic suppression in vitro Blood 85 1995 3183 3190
80. Maltman J Pragnell IB Graham GJ Transforming growth factor β: is it a downregulator of stem cell inhibition by macrophage inflammatory protein-1α? Journal of Experimental Medicine 178 1993 925 932
81. Maltman J Pragnell IB Graham GJ Specificity and reciprocity in the interactions between TGF-β and macrophage inflammatory protein-1α Journal of Immunology 156 1996 1566 1571
82. Mantel C Kim YJ Cooper S Polymerization of murine macrophage inflammatory protein 1α inactivates its myelosuppressive effects in vitro: the active form is a monomer Proceedings of the National Academy of Sciences of the USA 90 1993 2232 2236
83. + cells purified from cord blood and fetal liver Experimental Hematology 23 1995 422 427
84. Maze R Sherry B Kwon BS Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1α Journal of Immunology 149 1992 1004 1009
85. Migdalska A Molineux G Demuynck H Growth inhibitory effects of transforming growth factor-β1 in vivo Growth Factors 4 1991 239 245
86. Miller KL Carlino JA Ogawa Y Alterations in erythropoiesis in TGF-β1 treated mice Experimental Hematology 20 1992 951 956
87. Monpezat J-P Frindel E Further studies on the biological activities of the CFU-S inhibitory tetrapeptide AcSDKP. II. The precise point of the cell cycle sensitive to AcSDKP. Studies on the effect of AcSDKP on GM-CFC and on the possible involvement of T-lymphocytes in the AcSDKP response Experimental Hematology 17 1989 1077 1080
88. Mummery CL Van Den Eijnden-Van Raaij AJM Type β transforming growth factors and activins in differentiating embryonal carcinoma cells, embryonic stem cells and early embryonic development International Journal of Developmental Biology 37 1993 169 182
89. Murohashi I Endho K Nishida S Differential effects of TGF-β1 on normal and leukemic human hematopoietic cell proliferation Experimental Hematology 23 1995 970 977
90. Murphy PM Chemokine receptors: structure, function and role in microbial pathogenesis Cytokine and Growth Factor Reviews 7 1996 47 64
91. Nibbs RJB Wylie SM Pragnell IB Graham GJ Cloning and characterisation of a novel murine beta-chemokine receptor, D6 Journal of Biological Chemistry 272 1997 12495 12504
92. Oberhammer FA Pavelka M Sharma S Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1 Proceedings of the National Academy of Sciences of the USA 89 1992 5408 5412
93. Ohishi K Katayama N Itoh R Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-β Blood 87 1996 1718 1727
94. Otsuka T Eaves CJ Humphries RK Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells Leukemia 5 1991 861 868
95. Owen-Lynch PJ Adams JA Brereton ML The effect of the chemokine rhMIP-1α, and a non-aggregating variant BB-10010, on blast cells from patients with acute myeloid leukaemia British Journal of Haematology 95 1996 77 84
96. Parkinson EK Graham GH Daubersies P A haemopoietic stem cell inhibitor (SCI/MIP-1α) also inhibits clonogenic-epidermal keratinocyte proliferation Journal of Investigative Dermatology 101 1993 113 117
97. 2: a single-factor alternative for multifactor cocktails Leukemia 9 supplement 1 1995 S48 S52
98. Paukovits WR Paukovits J Mechanism of action of granulopoiesis inhibiting factor (chalone). I. Evidence for a receptor protein on bone marrow cells Experimental Pathology 10 1975 343 352
99. Paukovits WR Laerum OD Isolation and synthesis of a hemoregulatory peptide Zeitschrift für Naturforschung 37c 1982 1279 1299
100. Paukovits WR Hergl A Schulte-Hermann R Hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys: a new synthetic derivative for avoiding dimerization and loss of inhibitory activity Molecular Pharmacology 38 1990 401 409
101. Paukovits WR Moser M-H Paukovits JB Pre-CFU-S quiescence and stem cell exhaustion after cytostatic drug treatment: protective effects of the inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK) Blood 81 1993 1755 1761
102. Paukovits WR Moser M-H Binder KA Paukovits JB Protection from arabinofuranosylcytosine and n -mustard-induced myelotoxicity using hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys monomer and dimer Blood 77 1991 1313 1319
103. Paukovits WR Guigon M Binder KA Prevention of hematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide Cancer Research 50 1990 328 332
104. Paulsen JE Sundbyhall K Enderesen L The peptide pyroglu-gin-gly-ser-asn isolated from mouse liver inhibits growth of rat hepatoma cell in vitro Carcinogenesis 12 1991 207 210
105. −) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin Journal of Experimental Medicine 183 1996 2551 2558
106. Ploemacher RE Brons NHC Isolation of hemopoietic stem cell subsets from murine bone marrow. II. Evidence for an early precursor of day 12 CFU-S and cells associated with radioprotective ability Experimental Hematology 16 1988 27 30
107. Ploemacher RE Brons RHC Separation of CFU-S from primitive cells responsible for reconstitution of the bone marrow hemopoietic stem cell compartment following irradiation: evidence for a pre-CFU-S cell Experimental Hematology 17 1989 263 266
108. Potten CS Loeffler M Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the Crypt Development 110 1990 1001 1020
109. Quesniaux FJ Graham GJ Pragnell IB Use of 5-fluorouracil to analyze the effect of macrophage inflammatory protein-1α on long-term reconstituting stem cells in vivo Blood 81 1993 1497 1504
110. + human hematopoietic progenitors Experimental Hematology 4 1996 1509 1515
111. Rieger K-J Saez-Servent N Papet M-P Involvement of human plasma angiotensin 1-converting enzyme in the degradation of the haemoregulatory peptide N -acetyl-seryl-aspartyllysyl-proline Biochemical Journal 296 1993 373 378
112. Robinson S Lenfant M Wdzieczak-Bakala J Riches A The molecular specificity of action of the tetrapeptide acetyl- N -ser-asp-lys-pro (AcSDKP) in the control of haemopopietic stem cell proliferation Stem Cells 11 1993 422 427
113. Rotello RJ Leiberman RC Purchio AF Gerschenson LE Coordinated regulation of apoptosis and cell proliferation by transforming growth factor β1 in cultured uterine epithelial cells Proceedings of the National Academy of Sciences of the USA 88 1991 3412 3415
114. Rousseau A Michaud A Chauvet M-T The hemoregulatory peptide N -acetyl-ser-asp-lys-pro is a natural and specific substrate of the N -terminal active site of human angiotensin-converting enzyme Journal of Biological Chemistry 270 1995 3656 3661
115. Samson M Labbe O Mollereau C Molecular cloning and functional expression of a new human CC-chemokine receptor gene Biochemistry 35 1996 3362 3367
116. Schall TJ Biology of the RANTES/SIS cytokine family Cytokine 3 1991 165 183
117. Schull MM Ormsby I Kier AB Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease Nature 359 1992 693 699
118. Selleri C Maciejewski JP Sato T Interferon-γ constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition Blood 87 1996 4149 4157
119. Sitnicka E Ruscetti FW Priestley GV Transforming growth factor β1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells Blood 88 1996 82 88
120. + human hematopoietic progenitor cells Journal of Experimental Medicine 180 1994 1177 1182
121. Soma T Yu JM Dunbar CE Maintenance of murine long-term repopulating stem cells in ex vivo culture is affected by modulation of transforming growth factor-β but not macrophage inflammatory protein-1α activities Blood 87 1996 4561 4567
122. Sporn MB Roberts AB Transforming growth factor-β: recent progress and new challenges Journal of Cell Biology 119 1992 1017 1021
123. Sporn MB Roberts AB Wakefield LM de Crombrugghe B Some recent advances in the chemistry and biology of transforming growth factor-β Journal of Cell Biology 105 1987 1039 1045
124. Taetle R Payne C Dos Santos B Effects of transforming growth factor β1 on growth and apoptosis of human acute myelogenous leukemia cells Cancer Research 53 1993 3386 3393
125. Testa NG Molineux G Haemopoiesis: A Practical Approach 1993 IRL Press Oxford
126. Van Troys M Dewitte D Goethals M The acting binding site of thymosin β4 mapped by mutational analysis EMBO Journal 15 1996 201 208
127. Veiby OP Lovhaug D Fjerdingstad H Engelsen SJ Indirect stimulation of hemopoiesis by hemoregulatory peptide (HP5b) dimer in murine long-term bone marrow cultures Experimental Hematology 20 1992 192 195
128. Veiby OP Jacobsen FW Cui L The flt3 ligand promotes the survival of primitive hemopoetic progenitor cells with myeloid as well as B lymphoid potential: suppression of apoptosis and counteraction by TNF-α and TGF-β1 Journal of Immunology 157 1996 2953 2960
129. Watanabe T Brown GS Kelsey LS In vivo protective effects of tetrapeptide AcSDKP, with or without granulocyte colony-stimulating factor, on murine progenitor cells after sublethal irradiation Experimental Hematology 24 1996 713 721
130. Weber A Nachimas VT Pennise CR Interaction of thymosin-β4 with muscle and platelet actin: implications for actin sequestration in resting platelets European Journal of Cell Biology 61 1992 314 320
131. Wierenga PK Konings AWT Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage Experimental Hematology 24 1996 246 252
132. Wieser R Wrana JL Massague J GS domain mutations that constitutively activate TßR-1, the downstream signaling component in the TGF-β receptor complex EMBO Journal 14 1995 2199 2208
133. Wieser R Attisano L Wrana JL Massague J Signaling activity of transforming growth factor β Type II receptors lacking specific domains in the cytoplasmic region Molecular and Cellular Biology 13 1993 7239 7247
134. Williams GT Smith CA Spooncer E Dexter TM Haemopoietic colony-stimulating factors promote cell survival by suppressing apotosis Nature 343 1990 76 79
135. Zhang Y Harada A Bluethmann H Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNFα in vitro Blood 86 1995 2930 2937